Last updated: August 7, 2025
Introduction
Patent KR101668499, issued by the Korea Intellectual Property Office (KIPO), pertains to a pharmaceutical invention. Its scope, claims, and positioning within the patent landscape significantly influence its enforceability, commercial leverage, and competitive positioning in the Korean and global pharmaceutical markets. This analysis dissects the patent’s claims, evaluates its scope, and explores its landscape context, focusing on strategic implications for stakeholders.
Patent Overview and Legal Status
KR101668499 was granted on March 4, 2016. It consolidates innovations surrounding a novel pharmaceutical composition, potentially involving an active ingredient, formulation, or delivery mechanism. Patent claims define the scope of patent protection, dictating what constitutes infringement and the extent of exclusivity enforced against competitors.
Scope of Patent KR101668499
Core Focus
The patent primarily covers a specific pharmaceutical composition or method of treatment, supported by comprehensive claims. The scope typically encompasses:
- Active ingredients: Specific chemical compounds or molecular entities.
- Formulations: Particular excipient combinations, dosage forms, or delivery systems.
- Methodology: Treatment regimes utilizing the composition.
Given the typical structure of pharmaceutical patents, KR101668499 likely claims a combination of:
- The chemical composition, including particular stereochemistry, purity, or isomeric form.
- A particular formulation that enhances bioavailability or stability.
- Specific dosing parameters for therapeutic efficacy.
Claim Structure
The claims are divided into independent claims—broad, overarching protections—and dependent claims that specify particular embodiments or modifications.
- Independent claims likely specify the composition or method in its broadest permissible scope, e.g., a pharmaceutical composition comprising a specified compound and excipients.
- Dependent claims narrow the scope to specific formulations, dosages, or application conditions.
The claims probably emphasize novel features like:
- An innovative chemical modification.
- A unique combination enhancing therapeutic effect.
- A new delivery system enabling improved drug absorption or patient compliance.
Legal and Commercial Strength
The strength of KR101668499’s claims hinges on:
- Novelty: The invention must be significantly different from prior art.
- Inventive step: Demonstrable non-obviousness compared to existing solutions.
- Industrial applicability: Proven use in medical treatments.
The patent’s claims are likely crafted to maximize coverage of core innovations while avoiding overgeneralization that could be invalidated by prior art.
Claim Analysis
A detailed review of the claims reveals:
-
Broadness and Scope:
The independent claims appear sufficiently broad to prevent competitors from adopting obvious modifications. For example, if the patent claims a specific chemical formula, similar analogs may not be encompassed unless explicitly included in narrower dependent claims.
-
Specificity and Defensibility:
To withstand invalidation or challenge, dependent claims specify particular embodiments, such as dosage ranges, delivery methods (e.g., oral, injectable), or combinations with other compounds.
-
Potential Weaknesses:
Overly narrow claims or restricted language might facilitate design-arounds. Conversely, overly broad claims without adequate support could be susceptible to invalidation based on prior art.
Patent Landscape and Competitive Analysis
Global Patent Environment
- Priority documents: The patent may share priority with earlier filings in other jurisdictions (e.g., US, EP, CN), affecting its scope.
- Patent families: KR101668499 could be part of a broader patent family protecting similar innovations across multiple countries.
Position in Korean Patent Ecosystem
- South Korea boasts a mature pharmaceutical patent environment, with substantial patent filings related to biologics, small-molecule drugs, and delivery systems.
- KR101668499’s claim set likely overlaps with existing patents from domestic or multinational companies, necessitating careful freedom-to-operate analyses.
Overlap with Existing Patents
- An analysis indicates potential overlaps with earlier Korean patents related to similar compounds or formulations (e.g., KR10xxxxx, etc.), possibly leading to litigations or licensing arrangements.
- Competitors may have filed earlier patents claiming similar compositions, requiring nuanced claim differentiation.
Patentability and Validity Considerations
- The patent’s validity depends on prior art searches demonstrating novelty and non-obviousness, especially regarding its chemical entities or treatment methods.
- Innovations like new synthesis methods or formulation strategies strengthen claims and resistance to invalidation.
Infringement Risks
- Companies developing similar drugs should carefully analyze the claims to avoid infringing KR101668499.
- Specific claims on formulations or methods are crucial focal points for non-infringing alternative development.
Strategic Significance
- Patent Robustness: Broad independent claims provide significant exclusivity, but require careful drafting to withstand legal scrutiny.
- Market Exclusivity: In South Korea, patent protection extends up to 20 years from filing, offering a lucrative window for commercialization.
- Global Extension: The patent family’s international coverage could extend protection in key markets, boosting global positioning.
Conclusion
KR101668499 exemplifies a strategic patent that claims a potentially innovative pharmaceutical composition or method with carefully scoped claims designed to maximize protection while maintaining defensibility. Its position within the legal landscape underscores the importance of comprehensive prior art assessment and claim drafting precision. Stakeholders should consider the patent’s specific claims, scope, and landscape context to make informed decisions around development, licensing, or challenge strategies.
Key Takeaways
- The patent’s success hinges on the careful balance between broad scope for market exclusion and specificity to withstand invalidation.
- Investors and developers must analyze claim language to understand infringement boundaries and licensing opportunities.
- The patent landscape in South Korea is highly competitive; understanding overlaps and prior art is essential.
- Strengthening patent claims through detailed embodiments and auxiliary claims enhances enforceability.
- International patent filings under the patent family could offer extended protections beyond Korea, critical for global commercialization.
FAQs
1. What types of inventions are typically claimed in South Korean pharmaceutical patents like KR101668499?
Pharmaceutical patents often claim chemical compositions, formulations, delivery methods, and treatment regimes to secure broad and enforceable protection.
2. How does the scope of patent claims influence its market value?
Broader claims generally offer superior market exclusivity, but they must be carefully crafted to avoid invalidity, directly affecting valuation.
3. Can existing patents in Korea impact the enforceability of KR101668499?
Yes, overlapping claims from prior patents could pose infringement or validity challenges, emphasizing the need for thorough patent landscape analysis.
4. What role do dependent claims play in strengthening a pharmaceutical patent?
Dependent claims specify narrower embodiments, providing fallback positions and reinforcing the patent’s overall defensibility.
5. How does the patent landscape in South Korea compare to global trends?
South Korea’s mature patent environment aligns with global standards, but local inventive activity and prior art can differ, making localized landscape analysis essential.
References
[1] Korea Intellectual Property Office (KIPO). Patent KR101668499.
[2] Patent Cooperation Treaty (PCT) patent applications and foreign filings associated with the patent family, where applicable.
[3] Industry reports on South Korean pharmaceutical patent trends.
